Maxcyte (MXCT) Non-Current Debt (2020)
Maxcyte (MXCT) reported Non-Current Debt of $4.9 million for Q4 2020.
Maxcyte (MXCT) has 1 years of Non-Current Debt data on file, last reported at $4.9 million in Q4 2020.
- Quarterly Non-Current Debt changed N/A year-over-year to $4.9 million in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $4.9 million (changed N/A YoY) and the FY2020 annual result came in at $4.9 million, changed N/A from the prior year.
- Non-Current Debt was little changed at $4.9 million in Q4 2020 per MXCT's latest filing.
- Across five years, Non-Current Debt topped out at $4.9 million in Q4 2020 and bottomed at $4.9 million in Q4 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 29.64 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.22 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 27.88 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 10.99 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.13 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 1.81 Bn |
| 10 | Maxcyte | 129.85 Mn | 129.85 Mn | 8.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 4.92 Mn |
| Dec 31, 2020 | 4.92 Mn |